Failure of 6-hydroxynoradrenaline to produce degeneration of catecholamine neurons.
D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D006321:Heart / Q000187:drug effects; D006325:Heart Atria / Q000187:drug effects; D006651:Histocytochemistry; D006892:Hydroxydopamines / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008856:Microscopy, Fluorescence; D009206:Myocardium / Q000378:metabolism; D009410:Nerve Degeneration / Q000187:drug effects*; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000008:administration & dosage / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology* / Q000031:analogs & derivatives; D012110:Reserpine / Q000494:pharmacology; D014316:Tritium
D006892:Hydroxydopamines; D014316:Tritium; C002636:6-hydroxynoradrenaline; D012110:Reserpine; D004299:Dopamine beta-Hydroxylase; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine